British biopharmaceutical giant AstraZeneca plans to invest $50 billion in the United States by 2030, expanding its presence in the company's largest market.

Apple's Tim Cook spoke by satellite and 20 other AI and tech executives joined the White House to discuss onshoring and building up American manufacturing.

Johnson & Johnson is reportedly nearing enough support to finalize a $6.5 billion settlement for lawsuits related to cancer cases linked to its baby powder and other talc products.

A Securities and Exchange Commission process for approving shareholder proposals favors a left-wing bent in corporate policies, claims a watchdog, citing audits from 2018-2022.

Johnson & Johnson has added Israel to its Customer Connect order management website after questions rose over why it was excluded while "Palestine" was not.

Through a bankruptcy filing of its subsidiary company, J&J will be able to resolve about 99.75% of the pending talc lawsuits against the company and its affiliates in the U.S.

A federal judge said Johnson & Johnson shareholders may pursue as a class action their lawsuit accusing the company of concealing how its talc products were contaminated by asbestos.

More than 40 groups have signed onto a letter asking Congress to end the prescription drug price control scheme included in the Inflation Reduction Act.

Rep. Jeff Van Drew, a Cape May Republican and former Democrat, said if he decides to run against Sen. Robert Menendez or for his seat, he will win.

Johnson & Johnson announced that it's ditching the classic cursive script it has used for 130 years in favor of a revamped logo that pays homage to the old design.